Our Portfolio

Sun Capital Partners, Inc. is a trusted partner that is recognized for its investment and operational experience, including particular expertise in the consumer products and services, food and beverage, industrial, packaging, chemicals, building products, and automotive sectors. Since 1995, Sun Capital has invested in more than 365 companies worldwide across a broad range of industries and transaction structures with revenues of approximately $50 billion.


NextPharma is one of the leading global providers of contract manufacturing, product development, clinical trials and logistics services to the pharmaceutical and biotechnology industries, offering both conventional technologies and specialist technologies.